https://www.selleckchem.com/pr....oducts/bibo-3304-tri
Introduction Anti-inflammatory, topical therapy of severe keratitis in Dry Eye Disease (DED) and ocular Graft-versus-Host Disease (oGvHD) includes steroids, cyclosporine (Cs) and others. In Germany a commercial product containing 0.1 % Cs in a cationic formulation is available since 2015. Objective The aim of this study was to present real-life data using cationic 0.1 % Cs in oGvHD patients. Methods Retrospective study of n=26 oGvHD and n=41 DED patients with corneal staining of at least Oxford grade III. Parameters a
Aimer
Commentaire
Partagez
